Published in J Virol on November 05, 2008
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest (2009) 1.10
Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation (2012) 1.08
Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms. Neoplasia (2010) 1.06
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol (2011) 1.01
Virus infection, antiviral immunity, and autoimmunity. Immunol Rev (2013) 1.00
Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS One (2011) 0.94
Molecular control of monocyte development. Cell Immunol (2014) 0.92
Murine immunodeficiency virus-induced peripheral neuropathy and the associated cytokine responses. J Immunol (2012) 0.90
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol (2012) 0.88
Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar Drugs (2012) 0.87
Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. Viral Immunol (2009) 0.86
Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J Neurotrauma (2011) 0.86
Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis. Arch Biochem Biophys (2011) 0.86
Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK). Clin Exp Immunol (2010) 0.86
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clin Immunol (2009) 0.83
Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K. Clin Exp Immunol (2012) 0.83
Human metapneumovirus antagonism of innate immune responses. Viruses (2012) 0.81
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases. Biomed Res Int (2014) 0.79
SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells. J Immunol (2012) 0.79
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients. J Neurol Sci (2011) 0.79
Inhibition of Theiler's virus-induced apoptosis in infected murine macrophages results in necroptosis. Virus Res (2014) 0.79
SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis. J Immunol (2015) 0.77
Morphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS model. J Neuroimmunol (2014) 0.75
Shp1 function in myeloid cells. J Leukoc Biol (2017) 0.75
Nonclassical Monocytes Mediate Secondary Injury, Neurocognitive Outcome, and Neutrophil Infiltration after Traumatic Brain Injury. J Immunol (2017) 0.75
Multiple sclerosis. N Engl J Med (2000) 12.69
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol (1980) 11.52
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol (2004) 8.65
Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med (2008) 3.08
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer (2006) 3.05
Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol (2004) 2.95
Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods (1994) 2.85
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol (2003) 2.58
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog (1987) 2.56
Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol (2006) 2.53
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci (2002) 2.53
Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci (2003) 2.52
Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol (1995) 2.34
Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol (2008) 2.29
The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol (2005) 2.26
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol (1995) 2.06
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol (1998) 1.96
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol (1998) 1.91
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology (1990) 1.90
Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol (1998) 1.86
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol (1991) 1.84
Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol (1995) 1.83
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol (1999) 1.83
Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol (1982) 1.81
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol (1986) 1.76
The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci (2005) 1.74
Macrophages and neurodegeneration. Brain Res Brain Res Rev (2005) 1.64
Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol (2007) 1.63
The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia (1995) 1.55
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci (1976) 1.52
Role of macrophages during Theiler's virus infection. J Virol (1997) 1.52
Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol (1992) 1.47
Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol (2007) 1.31
Neuropathology of multiple sclerosis-new concepts. Brain Res Bull (2003) 1.31
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol (2001) 1.28
Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J Leukoc Biol (1987) 1.28
Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol (2002) 1.28
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain (2007) 1.24
Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am J Respir Cell Mol Biol (2004) 1.19
src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest (2003) 1.19
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol (1995) 1.19
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1. J Neuroimmunol (2002) 1.18
Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol (1988) 1.18
ADAM family proteins in the immune system. Immunol Today (1999) 1.17
Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis Methods (1996) 1.15
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res (2006) 1.15
Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome. J Biol Chem (2002) 1.13
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett (2002) 1.13
Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol (2004) 1.10
Activity of a newly identified serine protease in CNS demyelination. Brain (2002) 1.08
Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia (2000) 1.08
A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. J Neuroimmunol (2001) 1.07
Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res (1995) 1.07
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol Chem (2008) 1.06
Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J Neurosci (2000) 1.06
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest (2008) 1.05
Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J Leukoc Biol (2008) 1.05
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol (1999) 1.04
Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol (2002) 1.03
Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J Neurochem (2004) 1.02
Macrophage depletion diminishes implant-wear-induced inflammatory osteolysis in a mouse model. J Biomed Mater Res A (2008) 1.01
Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur J Immunol (1995) 1.00
Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions. J Virol (2003) 1.00
Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol (2003) 0.99
Liposome mediated affection of monocytes. Immunobiology (1992) 0.99
Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur J Immunol (2005) 0.99
Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice. J Neurosci Res (2004) 0.97
Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J Neuroimmunol (2006) 0.97
Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia (2005) 0.97
Maturation and localization of macrophages and microglia during infection with a neurotropic murine coronavirus. Brain Pathol (2007) 0.96
Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages. J Virol (2002) 0.96
Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B. Cell Immunol (1998) 0.95
The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen. Immunology (1989) 0.95
Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res (1998) 0.94
Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int Immunol (1990) 0.94
Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice. Intervirology (1997) 0.94
The detection of ADAM8 protein on cells of the human immune system and the demonstration of its expression on peripheral blood B cells, dendritic cells and monocyte subsets. Immunobiology (2006) 0.93
CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur J Immunol (1998) 0.93
Simplified quantitative analysis of spinal cord cells from Theiler's virus-infected mice without the requirement for myelin debris removal. J Immunol Methods (2005) 0.93
Macrophages in multiple sclerosis. Immunobiology (1996) 0.92
CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45(high)CD11b(+) monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol (2003) 0.92
Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain. J Comp Neurol (2001) 0.91
Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia (2001) 0.91
Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus. J Virol (2002) 0.90
Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy. J Neurol Sci (2007) 0.90
The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease. Curr Top Microbiol Immunol (2008) 0.89
Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia. Glia (2006) 0.87
Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia. J Neurochem (2008) 0.87
CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Viral Immunol (2007) 0.86
Natural cases of visna in sheep with myelitis as the sole lesion in the central nervous system. J Comp Pathol (2006) 0.85
Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neurovirol (2006) 0.85
The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells. J Immunol (1996) 0.85
Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol (2008) 1.59
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest (2009) 1.10
Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease. Inflamm Bowel Dis (2012) 1.07
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest (2008) 1.05
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol (2011) 1.01
Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines. J Neurochem (2008) 0.96
Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes. J Neuroimmunol (2002) 0.88
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol (2012) 0.88
Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia. Glia (2006) 0.87
Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia. J Neurochem (2008) 0.87
Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1. Viral Immunol (2009) 0.86
Chronic foot shock induces hyperactive behaviors and accompanying pro- and anti-inflammatory responses in mice. J Neuroimmunol (2007) 0.86
Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis. Brain Pathol (2012) 0.85
Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling. J Immunol (2013) 0.85
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clin Immunol (2009) 0.83
Antibody induction of lupus-like neuropsychiatric manifestations. J Neuroimmunol (2006) 0.83
Immune changes during acute cold/restraint stress-induced inhibition of host resistance to Listeria. Toxicol Sci (2003) 0.82
Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1. Neuron Glia Biol (2006) 0.82
Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via beta1-adrenergic receptors. Brain Behav Immun (2003) 0.82
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients. J Neurol Sci (2011) 0.79
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response. Biol Chem (2014) 0.77
Erratum to "Antibody induction of lupus-like neuropsychiatric manifestations" [J.Neuroimmunol.182(2007) 185-194]. J Neuroimmunol (2007) 0.75